SLC12A2 and nervous system disorder: Here we determine cryo-EM structures of human NKCC1 bound with bumetanide, providing an initial blueprint to enable the development of NKCC1- and NKCC2-specific inhibitors for the treatment of neurological disorders versus edema/hypertension.